CRISAFULLI, Ernesto
 Distribuzione geografica
Continente #
NA - Nord America 3.409
AS - Asia 2.908
EU - Europa 1.618
SA - Sud America 384
AF - Africa 159
Continente sconosciuto - Info sul continente non disponibili 101
OC - Oceania 4
Totale 8.583
Nazione #
US - Stati Uniti d'America 3.316
SG - Singapore 1.046
CN - Cina 777
VN - Vietnam 394
IE - Irlanda 361
IT - Italia 335
BR - Brasile 304
SE - Svezia 256
HK - Hong Kong 231
TR - Turchia 149
DE - Germania 134
FR - Francia 129
BD - Bangladesh 118
ZA - Sudafrica 111
FI - Finlandia 110
NL - Olanda 92
GB - Regno Unito 56
CA - Canada 45
IN - India 43
AR - Argentina 27
RU - Federazione Russa 26
MX - Messico 25
BE - Belgio 23
IQ - Iraq 21
PK - Pakistan 16
CI - Costa d'Avorio 15
UA - Ucraina 15
VE - Venezuela 15
AT - Austria 14
EC - Ecuador 13
KR - Corea 13
PL - Polonia 12
TH - Thailandia 11
UZ - Uzbekistan 11
CO - Colombia 10
ES - Italia 10
ID - Indonesia 10
CZ - Repubblica Ceca 9
LT - Lituania 9
JP - Giappone 8
PY - Paraguay 8
TN - Tunisia 8
MA - Marocco 7
CR - Costa Rica 6
JO - Giordania 6
KE - Kenya 6
SA - Arabia Saudita 6
AZ - Azerbaigian 5
PH - Filippine 5
EG - Egitto 4
HU - Ungheria 4
KZ - Kazakistan 4
OM - Oman 4
BG - Bulgaria 3
CL - Cile 3
DK - Danimarca 3
GE - Georgia 3
IL - Israele 3
IR - Iran 3
JM - Giamaica 3
MY - Malesia 3
NI - Nicaragua 3
RO - Romania 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
AU - Australia 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
LB - Libano 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PE - Perù 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AG - Antigua e Barbuda 1
AL - Albania 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
CG - Congo 1
CH - Svizzera 1
CY - Cipro 1
DZ - Algeria 1
ET - Etiopia 1
EU - Europa 1
GI - Gibilterra 1
GP - Guadalupe 1
GT - Guatemala 1
HR - Croazia 1
IM - Isola di Man 1
IS - Islanda 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LU - Lussemburgo 1
MT - Malta 1
MZ - Mozambico 1
Totale 8.474
Città #
Singapore 504
Ashburn 462
Chandler 399
Dublin 360
San Jose 360
Santa Clara 337
Hong Kong 224
Dearborn 180
Beijing 155
Ho Chi Minh City 121
Izmir 116
Johannesburg 106
Council Bluffs 103
Nanjing 100
Hanoi 93
Boardman 85
Dallas 84
Princeton 80
Parma 74
Lauterbourg 68
Ann Arbor 66
New York 60
Shanghai 60
Los Angeles 56
Wilmington 54
Bremen 40
Helsinki 36
Shenyang 36
Munich 32
Columbus 30
Buffalo 27
Milan 27
São Paulo 24
Hebei 23
Nanchang 23
Brussels 22
Da Nang 22
Haiphong 21
Tianjin 21
The Dalles 19
Düsseldorf 18
Moscow 18
Seattle 18
Stockholm 18
Hefei 17
Jacksonville 17
Jiaxing 16
Jinan 16
Sanayi 16
Abidjan 15
Houston 15
Changsha 14
Rio de Janeiro 14
Frankfurt am Main 13
London 13
San Mateo 13
Toronto 13
Vienna 13
Montreal 12
Guangzhou 11
Kunming 11
Turku 11
Washington 11
Baghdad 10
Brasília 10
Brooklyn 10
Des Moines 10
Rome 10
Tashkent 10
Woodbridge 10
Zhengzhou 9
Norwalk 8
Tokyo 8
Atlanta 7
Belo Horizonte 7
Denver 7
Fremont 7
Haikou 7
Hải Dương 7
Lahore 7
Mexico City 7
Ningbo 7
Phoenix 7
Pune 7
Redmond 7
Warsaw 7
Ankara 6
Bari 6
Biên Hòa 6
Bologna 6
Caracas 6
Dhaka 6
Jakarta 6
Marseille 6
Nairobi 6
Naples 6
Rio Saliceto 6
San Francisco 6
Taizhou 6
Amman 5
Totale 5.312
Nome #
Polmonite interstiziale con caratteristiche autoimmuni (IPAF) Interstitial pneumonia with autoimmune features (IPAF 185
A pulmonary infection by Actinomyces odontolyticus and Veillonella atypica in an immunocompetent patient with dental caries 174
Relationships between emphysema and airways metrics at High-Resolution Computed Tomography (HRCT) and ventilatory response to exercise in mild to moderate COPD patients 165
Prevalence of Depression in Sarcoidosis: a comparison with asthmatic and healthy controls 161
Next generation beta adrenoreceptor agonists for the treatment of asthma 160
Prevalence of Small-Airway Dysfunction among COPD Patients with Different GOLD Stages and Its Role in the Impact of Disease 155
Are interstitial lung abnormalities associated with COPD? A nested case–control study 155
A high degree of dyspnea is associated with poor maximum exercise capacity in subjects with copd with the same severity of air-flow obstruction 154
Asymptomatic peripheral artery disease can limit maximal exercise capacity in chronic obstructive pulmonary disease patients regardless of airflow obstruction and lung hyperinflation 154
Carfilzomib: A tale of a heartbreaking moment: Case report and concise review of the literature 153
Efficacy of standard rehabilitation in COPD outpatients with comorbidities. 152
Acute exacerbations of COPD: Risk factors for failure and relapse 148
Heart rate recovery is associated with ventilatory constraints and excess ventilation during exercise in patients with chronic obstructive pulmonary disease 144
C-reactive protein at discharge, diabetes mellitus and ≥1 hospitalization during previous year predict early readmission in patients with acute exacerbation of chronic obstructive pulmonary disease 143
The role of the microbiome in childhood asthma 141
COPD and the metabolic syndrome: An intriguing association 130
Cough, a vital reflex. mechanisms, determinants and measurements 130
Pulmonary hernia: Case report and review of the literature 127
Clinical variables predicting the risk of a hospital stay for longer than 7 days in patients with severe acute exacerbations of chronic obstructive pulmonary disease: A prospective study 127
Impact of bronchiectasis on outcomes of hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease: A propensity matched analysis 124
The value of high-resolution computed tomography (HRCT) to determine exercise ventilatory inefficiency and dynamic hyperinflation in adult patients with cystic fibrosis 124
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 123
Transthoracic Echocardiography and Chest Computed Tomography Arteriography in Patients with Acute Pulmonary Embolism: A Two-Year Follow-Up Study 123
Effects of beclomethasone/formoterol fixed combination on lung hyperinflation and dyspnea in COPD patients. 122
Intrapulmonary percussive ventilation in tracheostomized patients: A randomized controlled trial 122
Assessment of severity of ICU-acquired pneumonia and association with etiology 122
Energy expenditure at rest and during walking in patients with chronic respiratory failure: a prospective two-phase case-control study. 121
Pleuritis with pleural effusion due to a Bacillus megaterium infection 116
Minimum clinically important difference in 30-s sit-to-stand test after pulmonary rehabilitation in subjects with copd 116
Exercise capacity as a pulmonary rehabilitation outcome 115
Reduced exercise ventilatory efficiency in adults with cystic fibrosis and normal to moderately impaired lung function 115
Looking for Predictors of Early Readmission in COPD: Every Effort Is Required 113
Inhaled beclometasone dipropionate/formoterol fumarate extrafine fixed combination for the treatment of asthma 110
Anthropometry in Special and Selective Conditions and Circumstances: Anthropometry as Measure of Risk in COPD Patients 109
Readmission for acute exacerbation within 30 days of discharge is associated with a subsequent progressive increase in mortality risk in COPD patients: A long-Term observational study 107
Spot the trachea! A wide paratracheal air cyst of not easy definition 107
Do we now have a couch potato blood test? 106
Diagnosis of Chronic Obstructive Pulmonary Disease, simpler is better Complexity and simplicity 106
Effects of early inpatient rehabilitation after acute exacerbation of COPD 106
Raccomandazioni Italiane sulla Pneumologia Riabilitativa. Evidenze scientifiche e messaggi clinico-pratici 102
Physiological predictors of exertional oxygen desaturation in patients with fibrotic interstitial lung disease 102
Early rehabilitation: Much better than nothing 101
Co-morbidities in chronic respiratory patients: limitations or opportunities for caring? 100
Sarcoidosis in an Italian province. Prevalence and environmental risk factors 100
Flow and volume response to bronchodilator in patients with COPD 98
Respiratory muscle training in patients recovering recent open cardiothoracic surgery: A randomized-controlled trial 97
Activity and analysis of costs in a dedicated weaning centre 96
Cost-effectiveness of NIV applied to chronic respiratory failure 95
Home non-invasive mechanical ventilation and long-term oxygen therapy in stable hypercapnic chronic obstructive pulmonary disease patients: Comparison of costs 94
Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation 91
Effectiveness of erdosteine in elderly patients with bronchiectasis and hypersecretion: A 15-day, prospective, parallel, open-label, pilot study 91
Measures of dyspnea in pulmonary rehabilitation 90
Short-term efficacy of upper-extremity exercise training in patients with chronic airway obstruction: A systematic review 88
Subjective sleep quality during average volume assured pressure support (AVAPS) ventilation in patients with hypercapnic COPD: A physiological pilot study 87
Effects of unsupported upper extremity exercise training in patients with COPD: A randomized clinical trial 87
Functional recovery following physical training in tracheotomized and chronically ventilated patients 86
Systemic inflammatory pattern of patients with community-acquired pneumonia with and without COPD 86
Baseline exercise tolerance and perceived dyspnea to identify the ideal candidate to pulmonary rehabilitation: A risk chart in COPD patients 85
Effects of a walking aid in COPD patients receiving oxygen therapy 83
Inhaled corticosteroids do not influence the early inflammatory response and clinical presentation of hospitalized subjects with COPD exacerbation 83
Impact of chronic liver disease in intensive care unit acquired pneumonia: A prospective study 82
Home-centred physical fitness programme in morbidly obese individuals: A randomized controlled trial 81
Repeated pulmonary rehabilitation in severe and disabled COPD patients 80
Rehabilitation in COPD patients admitted for exacerbation 80
Series "novelties in pulmonary rehabilitation": Determinants of success 80
Efficacy of temporary positive expiratory pressure (TPEP) in patients with lung diseases and chronic mucus hypersecretion. the UNIKO® project: A multicentre randomized controlled trial 76
Exercise performance after standard rehabilitation in COPD patients with lung hyperinflation 75
Endotracheal tubes for critically ill patients: An in vivo analysis of associated tracheal injury , mucociliary clearance, and sealing effi cacy 71
Feasibility and effectiveness of an educational program in Italian COPD patients undergoing rehabilitation 71
Predictors of Readmission in a Period of 30 Days or Less in Acute Exacerbation of Chronic Obstructive Pulmonary Disease 70
Pulmonary rehabilitation following radical chemo-radiation in locally advanced non surgical NSCLC: Preliminary evidences 67
Respiratory muscles training in COPD patients 67
Learning impact of education during pulmonary rehabilitation program. An observational short-term cohort study 67
Predicting poor prognosis in COPD patients: Looking for a lamp lit in the darkness of the night 66
Rehabilitation and supportive therapy in elderly patients with chronic obstructive pulmonary disease 66
Readmission in COPD patients: Should we consider it a marker of quality of care or a marker of a more severe disease with a worse prognosis?: To the editor 66
Erratum: Subjective sleep quality during Average Volume Assured Pressure Support (AVAPS) ventilation in patients with hypercapnic COPD: A physiological pilot study (Lung (2009) 187: 5 (299-305) DOI: 10.1007/s00408-009-9167-1) 65
Pneumonic and nonpneumonic exacerbations of COPD: Inflammatory response and clinical characteristics 64
Long-term weight loss and maintenance in morbidly obese individuals with obstructive sleep apnea 60
La Riabilitazione Respiratoria 58
Predicting walking-induced oxygen desaturations in COPD patients: A statistical model 55
Consumo energetico durante Test del Cammino in pazienti BPCO con Insufficienza Respiratoria Cronica 9
Totale 8.583
Categoria #
all - tutte 34.473
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.473


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022249 0 1 0 14 3 4 15 20 23 15 10 144
2022/20231.328 166 153 62 115 111 149 6 87 416 2 48 13
2023/2024472 28 54 19 9 50 124 17 45 15 31 27 53
2024/20251.727 24 104 123 105 265 255 29 69 150 158 133 312
2025/20263.173 295 256 326 266 519 161 337 96 391 233 170 123
2026/2027215 51 164 0 0 0 0 0 0 0 0 0 0
Totale 8.583